Carregant...
Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis
Hydralazine is a direct-acting vasodilator, which has been used in treatment for hypertension (HTN) since the 1950s. While it is well known to cause drug-induced lupus (DIL), recent reports are indicating the emergence of the drug-induced anti-neutrophil cytoplasmic antibody (ANCA) associated vascul...
Guardat en:
| Publicat a: | J Bras Nefrol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Sociedade Brasileira de Nefrologia
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533989/ https://ncbi.nlm.nih.gov/pubmed/29738027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/2175-8239-JBN-3858 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|